Abu Dhabi Investment Authority (ADIA) and HarbourVest are exploring the possibility of acquiring a minority stake in Cohance Lifesciences, a Hyderabad-based pharmaceutical platform owned by Advent International. The investment is expected to be around $350-400 million, valuing Cohance Lifesciences at approximately $1.5 billion. ADIA already has a presence in India’s pharmaceutical sector, owning a stake in Intas Pharmaceuticals.
ADIA, the Abu Dhabi Investment Authority, is interested in investing $600 million in Mukesh Ambani’s retail empire, Reliance Retail Ventures, at higher valuations than three years ago. Although the current valuation is much higher than before, it still falls short of what equity analysts believe the privately held retail business is worth. ADIA’s potential investment further strengthens the strategic relationship between the two companies, and an official stated that ADIA does not often invest at such premium valuations. Reliance Industries recently valued RRVL at $148 billion when buying out minority shareholders and employees.
